Screening and identification of novel biologically active natural compounds

F1000Research

Volumn 6, Issue , 2017, Pages

  Newman, David ^a  

^a Newman Consulting LLC   (United States)

Author keywords

Bioactive materials; Natural compounds; Natural products; Screening

Indexed keywords

BENGAMIDE B; BIOLOGICAL MARKER; LUCIFERASE; MICROSCLERODERMIN A; ONNAMIDE; PEDERIN; UNCLASSIFIED DRUG;

BIOLOGICAL ACTIVITY; CHEMICAL ANALYSIS; DRUG INDUSTRY; EPIGENETICS; FRACTIONATION; GENE CLUSTER; GENE MAPPING; GENOME; HUMAN; INVERTEBRATE; MAMMAL CELL; MARINE ENVIRONMENT; MASS SPECTROMETRY; METABOLOMICS; MICROORGANISM; MICROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; PLANT; REVIEW; SCREENING; TRANSGENIC ORGANISM;

EID: 85024493517     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.11221.1     Document Type: Review

References (94)

1. Newman DJ Cragg GM: Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod. 2016;79(3):629-61. 26852623 10.1021/acs.jnatprod.5b01055
2. Rask-Andersen M Zhang J Fabbro D: Advances in kinase targeting: current clinical use and clinical trials. Trends Pharmacol Sci. 2014;35(11):604-20. 25312588 10.1016/j.tips.2014.09.007
3. Fabbro D Cowan-Jacob SW Moebitz H: Ten things you should know about protein kinases: IUPHAR Review 14. Br J Pharmacol. 2015;172(11):2675-700. 25630872 10.1111/bph.13096 4439867 F1000 Recommendation
4. Lin A Giuliano CJ Sayles NM: CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials. eLife. 2017;6: pii: e24179. 28337968 10.7554/eLife.24179 5365317 F1000 Recommendation
5. Moffat JG Rudolph J Bailey D: Phenotypic screening in cancer drug discovery - past, present and future. Nat Rev Drug Discov. 2014;13(8):588-602. 25033736 10.1038/nrd4366
6. Swinney DC Anthony J: How were new medicines discovered? Nat Rev Drug Discov. 2011;10(7):507-19. 21701501 10.1038/nrd3480
7. Newman DJ: The Influence of Brazilian Biodiversity on Searching for Human Use Pharmaceuticals. J Braz Chem Soc. 2016. 10.21577/0103-5053.20160225
8. Nakamura K Iizuka R Nishi S: Culture-independent method for identification of microbial enzyme-encoding genes by activity-based single-cell sequencing using a water-in-oil microdroplet platform. Sci Rep. 2016;6:22259. 26915788 10.1038/srep22259 4768102
9. Wilson MC Mori T Ruckert C: An environmental bacterial taxon with a large and distinct metabolic repertoire. Nature. 2014;506(7486):58-62. 24476823 10.1038/nature12959 F1000 Recommendation
10. Freeman MF Vagstad AL Piel J: Polytheonamide biosynthesis showcasing the metabolic potential of sponge-associated uncultivated 'Entotheonella' bacteria. Curr Opin Chem Biol. 2016;31:8-14. 26625171 10.1016/j.cbpa.2015.11.002 F1000 Recommendation
11. Lackner G Peters EE Helfrich EJ: Insights into the lifestyle of uncultured bacterial natural product factories associated with marine sponges. Proc Natl Acad Sci U S A. 2017;114(3):E347-E356. 28049838 10.1073/pnas.1616234114 5255618 F1000 Recommendation
12. Munro MH Blunt JW Dumdei EJ: The discovery and development of marine compounds with pharmaceutical potential. J Biotechnol. 1999;70(1-3):15-25. 10412202 10.1016/S0168-1656(99)00052-8
13. Esquenazi E Yang YL Watrous J: Imaging mass spectrometry of natural products. Nat Prod Rep. 2009;26(12):1521-34. 19936384 10.1039/b915674g
14. Watrous JD Dorrestein PC: Imaging mass spectrometry in microbiology. Nat Rev Microbiol. 2011;9(9):683-94. 21822293 10.1038/nrmicro2634 3710447
15. Watrous JD Alexandrov T Dorrestein PC: The evolving field of imaging mass spectrometry and its impact on future biological research. J Mass Spectrom. 2011;46(2):209-22. 21322093 10.1002/jms.1876 3303182
16. Xu Y Kersten RD Nam SJ: Bacterial biosynthesis and maturation of the didemnin anti-cancer agents. J Am Chem Soc. 2012;134(20):8625-32. 22458477 10.1021/ja301735a 3401512 F1000 Recommendation
17. Tsukimoto M Nagaoka M Shishido Y: Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B. J Nat Prod. 2011;74(11):2329-31. 22035372 10.1021/np200543z
18. Doroghazi JR Albright JC Goering AW: A roadmap for natural product discovery based on large-scale genomics and metabolomics. Nat Chem Biol. 2014;10(11):963-8. 25262415 10.1038/nchembio.1659 4201863 F1000 Recommendation
19. Henke MT Kelleher NL: Modern mass spectrometry for synthetic biology and structure-based discovery of natural products. Nat Prod Rep. 2016;33(8):942-50. 27376415 10.1039/c6np00024j 4981503 F1000 Recommendation
20. Choi S Kim H Lee H: Genome mining of rare actinomycetes and cryptic pathway awakening. Process Biochemistry. 2015;50(8):1184-93. 10.1016/j.procbio.2015.04.008
21. Keller NP: Translating biosynthetic gene clusters into fungal armor and weaponry. Nat Chem Biol. 2015;11(9):671-7. 26284674 10.1038/nchembio.1897 4682562
22. Kleigrewe K Almaliti J Tian IY: Combining Mass Spectrometric Metabolic Profiling with Genomic Analysis: A Powerful Approach for Discovering Natural Products from Cyanobacteria. J Nat Prod. 2015;78(7):1671-82. 26149623 10.1021/acs.jnatprod.5b00301 4681511 F1000 Recommendation
23. Cuperlovic-Culf M Culf AS: Applied metabolomics in drug discovery. Expert Opin Drug Discov. 2016;11(8):759-70. 27366968 10.1080/17460441.2016.1195365
24. Floros DJ Jensen PR Dorrestein PC: A metabolomics guided exploration of marine natural product chemical space. Metabolomics. 2016;12:145. 10.1007/s11306-016-1087-5
25. Jensen PR: Natural Products and the Gene Cluster Revolution. Trends Microbiol. 2016;24(12):968-77. 27491886 10.1016/j.tim.2016.07.006 5123934
26. Adamek M Spohn M Stegmann E: Mining bacterial genomes for secondary metabolite gene clusters. In Antibiotics: Methods and Protocols. Methods Mol Biol. Sass P, Ed., Springer Science+Business Media: New York,2017;1520:23-47. 27873244 10.1007/978-1-4939-6634-9_2
27. Allard PM Genta-Jouve G Wolfender JL: Deep metabolome annotation in natural products research: towards a virtuous cycle in metabolite identification. Curr Opin Chem Biol. 2017;36:40-9. 28088695 10.1016/j.cbpa.2016.12.022
28. Covington BC McLean JA Bachmann BO: Comparative mass spectrometry-based metabolomics strategies for the investigation of microbial secondary metabolites. Nat Prod Rep. 2017;34(1):6-24. 27604382 10.1039/c6np00048g 5214543
29. Lamb J: The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer. 2007;7(1):54-60. 17186018 10.1038/nrc2044
30. Vaden RM Oswald NW Potts MB: FUSION-Guided Hypothesis Development Leads to the Identification of N 6, N 6-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor. Mar Drugs. 2017;15(3): pii: E75. 28294973 10.3390/md15030075 5367032 F1000 Recommendation
31. Hassig CA Zeng FY Kung P: Ultra-High-Throughput Screening of Natural Product Extracts to Identify Proapoptotic Inhibitors of Bcl-2 Family Proteins. J Biomol Screen. 2014;19(8):1201-11. 24870016 10.1177/1087057114536227 4521994
32. Hiraki M Hwang SY Cao S: Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis. Chem Biol. 2015;22(9):1206-16. 26320861 10.1016/j.chembiol.2015.07.016 4670040
33. Vafai SB Mevers E Higgins KW: Natural Product Screening Reveals Naphthoquinone Complex I Bypass Factors. PLoS One. 2016;11(9):e0162686. 27622560 10.1371/journal.pone.0162686 5021346
34. Schiewe HJ Zeeck A: Cineromycins, gamma-butyrolactones and ansamycins by analysis of the secondary metabolite pattern created by a single strain of Streptomyces. J Antibiot (Tokyo). 1999;52(7):635-42. 10513843 10.7164/antibiotics.52.635
35. Zähner H: Some aspects of antibiotics research. Angew Chem Int Ed Engl. 1977;16(10):687-94. 412435 10.1002/anie.197706871
36. Schmid I I Sattler I I Grabley S: Natural Products in High Throughput Screening: Automated High-Quality Sample Preparation. J Biomol Screen. 1999;4(1):15-25. 10838408 10.1177/108705719900400104 F1000 Recommendation
37. Eldridge GR Vervoort HC Lee CM: High-throughput method for the production and analysis of large natural product libraries for drug discovery. Anal Chem. 2002;74(16):3963-71. 12199561 10.1021/ac025534s
38. Abel U Koch C Speitling M: Modern methods to produce natural-product libraries. Curr Opin Chem Biol. 2002;6(4):453-8. 12133720 10.1016/S1367-5931(02)00338-1
39. Appleton DR Buss AD Butler MS: A Simple Method for High-Throughput Extract Prefractionation for Biological Screening. CHIMIA. 2007;61(6):327-31. 10.2533/chimia.2007.327
40. Wagenaar MM: Pre-fractionated microbial samples--the second generation natural products library at Wyeth. Molecules. 2008;13(6):1406-26. 18596666 10.3390/molecules13061406
41. Bugni TS Richards B Bhoite L: Marine natural product libraries for high-throughput screening and rapid drug discovery. J Nat Prod. 2008;71(6):1095-8. 18505284 10.1021/np800184g 2533854
42. Hou Y Braun DR Michel CR: Microbial strain prioritization using metabolomics tools for the discovery of natural products. Anal Chem. 2012;84(10):4277-83. 22519562 10.1021/ac202623g 3352271
43. Camp D Campitelli M Carroll AR: Front-loading natural-product-screening libraries for log P: background, development, and implementation. Chem Biodivers. 2013;10(4):524-37. 23576340 10.1002/cbdv.201200302
44. Henrich CJ Beutler JA: Matching the power of high throughput screening to the chemical diversity of natural products. Nat Prod Rep. 2013;30(10):1284-98. 23925671 10.1039/c3np70052f 3801163
45. Adnani N Ellis GA Wyche TP: Emerging trends for stimulating the discovery of natural products. In Natural Products Analysis: Instrumentation, Methods and Applications, Havlíček V; Spížek J, Eds. John Wiley & Sons Inc: New York,2014;115-161. 10.1002/9781118876015.ch5
46. Butler MS Fontaine F Cooper MA: Natural product libraries: assembly, maintenance, and screening. Planta Med. 2014;80(14):1161-70. 24310213 10.1055/s-0033-1360109
47. Fenner AM Gerwick WH: Marine Bioprospecting. In Natural Product: Discourse, Diversity and Design, Osbourn A.; Goss RJ; Carter GT, Eds. Wiley Blackwell: Oxford UK.2014;85-101. 10.1002/9781118794623.ch5
48. Gaudêncio SP Pereira F: Dereplication: racing to speed up the natural products discovery process. Nat Prod Rep. 2015;32(6):779-810. 25850681 10.1039/c4np00134f F1000 Recommendation
49. Schlotterbeck G Pasch H Albert K: On-line HPLC 1H NMR coupling for the analysis of fatty alcohol ethoxylates. Polym Bull. 1997;38(6):673-9. 10.1007/s002890050104
50. Romero CA Grkovic T Han J: NMR fingerprints, an integrated approach to uncover the unique components of the drug-like natural product metabolome of termite gut-associated Streptomyces species. RSC Adv. 2015;5:104524-34. 10.1039/C5RA17553D
51. Wang D Feng Y Murtaza M: A Grand Challenge: Unbiased Phenotypic Function of Metabolites from Jaspis splendens against Parkinson's Disease. J Nat Prod. 2016;79(2):353-61. 26883470 10.1021/acs.jnatprod.5b00987 F1000 Recommendation
52. Vial ML Zencak D Grkovic T: A Grand Challenge. 2. Phenotypic Profiling of a Natural Product Library on Parkinson's Patient-Derived Cells. J Nat Prod. 2016;79(8):1982-9. 27447544 10.1021/acs.jnatprod.6b00258 F1000 Recommendation
53. Fetz V Prochnow H Bronstrup M: Target identification by image analysis. Nat Prod Rep. 2016;33(5):655-67. 26777141 10.1039/c5np00113g F1000 Recommendation
54. Kurita KL Linington RG: Connecting phenotype and chemotype: High-content discovery strategies for natural products research. J Nat Prod. 2015;78(3):587-96. 25728167 10.1021/acs.jnatprod.5b00017 F1000 Recommendation
55. Kurita KL Glassey E Linington RG: Integration of high-content screening and untargeted metabolomics for comprehensive functional annotation of natural product libraries. Proc Natl Acad Sci U S A. 2015;112(39):11999-2004. 26371303 10.1073/pnas.1507743112 4593099 F1000 Recommendation
56. Guo CJ Wang CC: Recent advances in genome mining of secondary metabolites in Aspergillus terreus. Front Microbiol. 2014;5:717. 25566227 10.3389/fmicb.2014.00717 4274970
57. Bok JW Hoffmeister D Maggio-Hall LA: Genomic mining for Aspergillus natural products. Chem Biol. 2006;13(1):31-7. 16426969 10.1016/j.chembiol.2005.10.008 F1000 Recommendation
58. Wiemann P Keller NP: Strategies for mining fungal natural products. J Ind Microbiol Biotechnol. 2014;41(2):301-13. 24146366 10.1007/s10295-013-1366-3 F1000 Recommendation
59. Bignell E Cairns TC Throckmorton K: Secondary metabolite arsenal of an opportunistic pathogenic fungus. Philos Trans R Soc Lond B Biol Sci. 2016;371(1709): pii: 20160023. 28080993 10.1098/rstb.2016.0023 5095546
60. Henke MT Soukup AA Goering AW: New Aspercryptins, Lipopeptide Natural Products, Revealed by HDAC Inhibition in Aspergillus nidulans. ACS Chem Biol. 2016;11(8):2117-23. 27310134 10.1021/acschembio.6b00398 5119465
61. Plaza A Müller R: Myxobacteria: Chemical diversity and screening strategies. In Natural Products: Discourse, Diversity, and Design, Osbourn A, Goss RJ, Carter GT. John Wiley & Sons IPb, Eds. John Wiley & Sons, Inc: Hoboken NJ.2014;103-124. 10.1002/9781118794623.ch6
62. Zaburannyi N Bunk B Maier J: Genome Analysis of the Fruiting Body-Forming Myxobacterium Chondromyces crocatus Reveals High Potential for Natural Product Biosynthesis. Appl Environ Microbiol. 2016;82(6):1945-57. 26773087 10.1128/AEM.03011-15 4784028 F1000 Recommendation
63. Meusel M Hufsky F Panter F: Predicting the Presence of Uncommon Elements in Unknown Biomolecules from Isotope Patterns. Anal Chem. 2016;88(15):7556-66. 27398867 10.1021/acs.analchem.6b01015 F1000 Recommendation
64. Herrmann J Fayad AA Müller R: Natural products from myxobacteria: novel metabolites and bioactivities. Nat Prod Rep. 2017;34(2):135-60. 27907217 10.1039/c6np00106h F1000 Recommendation
65. Wenzel SC Hoffmann H Zhang J: Production of the Bengamide Class of Marine Natural Products in Myxobacteria: Biosynthesis and Structure-Activity Relationships. Angew Chem Int Ed Engl. 2015;54(51):15560-4. 26514647 10.1002/anie.201508277 F1000 Recommendation
66. Hoffmann H Haag-Richter S Kurz M: Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer. WO/2005/044803, Filing date 24OCT2003; Publication date 19MAY2005. Reference Source
67. Johnson TA Sohn J Vaske YM: Myxobacteria versus sponge-derived alkaloids: the bengamide family identified as potent immune modulating agents by scrutiny of LC-MS/ELSD libraries. Bioorg Med Chem. 2012;20(14):4348-55. 22705020 10.1016/j.bmc.2012.05.043 3417756
68. Hoffmann T Müller S Nadmid S: Microsclerodermins from terrestrial myxobacteria: an intriguing biosynthesis likely connected to a sponge symbiont. J Am Chem Soc. 2013;135(45):16904-11. 24124771 10.1021/ja4054509 F1000 Recommendation
69. Petras D Jarmusch AK Dorrestein PC: From single cells to our planet-recent advances in using mass spectrometry for spatially resolved metabolomics. Curr Opin Chem Biol. 2017;36:24-31. 28086192 10.1016/j.cbpa.2016.12.018
70. Quinn RA Nothias LF Vining O: Molecular Networking As a Drug Discovery, Drug Metabolism, and Precision Medicine Strategy. Trends Pharmacol Sci. 2017;38(2):143-54. 27842887 10.1016/j.tips.2016.10.011
71. Humbeck L Koch O: What Can We Learn from Bioactivity Data? Chemoinformatics Tools and Applications in Chemical Biology Research. ACS Chem Biol. 2017;12(1):23-35. 27779378 10.1021/acschembio.6b00706 F1000 Recommendation
72. González-Medina M Prieto-Martinez FD Naveja JJ: Chemoinformatic expedition of the chemical space of fungal products. Future Med Chem. 2016;8(12):1399-412. 27485744 10.4155/fmc-2016-0079 F1000 Recommendation
73. Kellogg JJ Todd DA Egan JM: Biochemometrics for Natural Products Research: Comparison of Data Analysis Approaches and Application to Identification of Bioactive Compounds. J Nat Prod. 2016;79(2):376-86. 26841051 10.1021/acs.jnatprod.5b01014 5135737 F1000 Recommendation
74. Williams RB Henrikson JC Hoover AR: Epigenetic remodeling of the fungal secondary metabolome. Org Biomol Chem. 2008;6(11):1895-7. 18480899 10.1039/b804701d F1000 Recommendation
75. Fisch KM Gillaspy AF Gipson M: Chemical induction of silent biosynthetic pathway transcription in Aspergillus niger. J Ind Microbiol Biotechnol. 2009;36(9):1199-213. 19521728 10.1007/s10295-009-0601-4
76. Henrikson JC Hoover AR Joyner PM: A chemical epigenetics approach for engineering the in situ biosynthesis of a cryptic natural product from Aspergillus niger. Org Biomol Chem. 2009;7(3):435-8. 19156306 10.1039/b819208a
77. Cichewicz RH: Epigenome manipulation as a pathway to new natural product scaffolds and their congeners. Nat Prod Rep. 2010;27(1):11-22. 20024091 10.1039/b920860g 2958777
78. Cichewicz RH Henrikson JC Wang X: Strategies for accessing microbial secondary metabolites from silent biosynthetic pathways. In Manual of Industrial Microbiology and Biotechnology, 3rd ed. Baltz RH, Demain AL, Davies JE, Eds. ASM Press: Washington D.C,2010;78-95. 10.1128/9781555816827.ch7
79. Truong TT Seyedsayamdost M Greenberg EP: A Burkholderia thailandensis Acyl-Homoserine Lactone-Independent Orphan LuxR Homolog That Activates Production of the Cytotoxin Malleilactone. J Bacteriol. 2015;197(21):3456-62. 26283771 10.1128/JB.00425-15 4621068 F1000 Recommendation
80. Okada BK Wu Y Mao D: Mapping the Trimethoprim-Induced Secondary Metabolome of Burkholderia thailandensis. ACS Chem Biol. 2016;11(8):2124-30. 27367535 10.1021/acschembio.6b00447 F1000 Recommendation
81. Watrous J Roach P Alexandrov T: Mass spectral molecular networking of living microbial colonies. Proc Natl Acad Sci U S A. 2012;109(26):E1743-52. 22586093 10.1073/pnas.1203689109 3387089 F1000 Recommendation
82. Mao D Bushin LB Moon K: Discovery of scmR as a global regulator of secondary metabolism and virulence in Burkholderia thailandensis E264. Proc Natl Acad Sci U S A. 2017;114(14):E2920-E2928. 28320949 10.1073/pnas.1619529114 5389298 F1000 Recommendation
83. Martin DF Kutt EC Kim YS: Use of a Multiple Diffusion Chamber Unit in Culture Studies. Application to Gomphosphaeria Aponina. Environ Lett. 2009;7(1):39-46. 10.1080/00139307409437382
84. Lebrun M de Repentigny J Mathieu LG: [Diminution of the antibacterial activity of antibiotics in cultures and in experimental mixed infections]. Can J Microbiol. 1978;24(2):154-61. 417782
85. Martin BB Martin DF: Use of the EcoloGen to study Hydrilla growth inhibitors. J Aquat Plant Manage. 1986;24:82-84. Reference Source
86. Cueto M Jensen PR Kauffman C: Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge. J Nat Prod. 2001;64(11):1444-6. 11720529 10.1021/np0102713 F1000 Recommendation
87. Oh DC Jensen PR Kauffman CA: Libertellenones A-D: induction of cytotoxic diterpenoid biosynthesis by marine microbial competition. Bioorg Med Chem. 2005;13(17):5267-73. 15993608 10.1016/j.bmc.2005.05.068
88. Oh DC Kauffman CA Jensen PR: Induced production of emericellamides A and B from the marine-derived fungus Emericella sp. in competing co-culture. J Nat Prod. 2007;70(4):515-20. 17323993 10.1021/np060381f
89. Bertrand S Azzollini A Schumpp O: Multi-well fungal co-culture for de novo metabolite-induction in time-series studies based on untargeted metabolomics. Mol Biosyst. 2014;10(9):2289-98. 24948000 10.1039/c4mb00223g
90. Barkal LJ Theberge AB Guo CJ: Microbial metabolomics in open microscale platforms. Nat Commun. 2016;7:10610. 26842393 10.1038/ncomms10610 4742997
91. Newman DJ Cragg GM: Endophytic and epiphytic microbes as "sources" of bioactive agents. Front Chem. 2015;3:34. 26052511 10.3389/fchem.2015.00034 4440917
92. Schorn MA Alanjary MM Aguinaldo K: Sequencing rare marine actinomycete genomes reveals high density of unique natural product biosynthetic gene clusters. Microbiology. 2016;162(12):2075-86. 27902408 10.1099/mic.0.000386
93. Patin NV Schorn M Aguinaldo K: Effects of Actinomycete Secondary Metabolites on Sediment Microbial Communities. Appl Environ Microbiol. 2017;83(4): pii: e02676-16. 27986719 10.1128/AEM.02676-16 5288833
94. Crüsemann M O'Neill EC Larson CB: Prioritizing Natural Product Diversity in a Collection of 146 Bacterial Strains Based on Growth and Extraction Protocols. J Nat Prod. 2017;80(3):588-97. 28335604 10.1021/acs.jnatprod.6b00722 5367486